Teva Pharmaceutical Industries Limited (NYSE:TEVA) tinted loss of -0.08% (-0.02 points) to US$23.73. The volume of 7.07 Million shares climbed up over an trading activity of 11.44 Million shares. EPS ratio determined by looking at last 12 month figures is -16.84. Over the same time span, the stock marked US$33.82 as its best level and the lowest price reached was US$10.85. The corporation has a market cap of US$24.76 Billion.
Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s earnings per share has been growing at a -57.5 percent rate over the past 5 year when average revenue increase was noted as 2 percent. The return on equity ratio or ROE stands at -82.2 percent while most common profitability ratio return on investment (ROI) was -36 percent. The company’s institutional ownership is monitored at 67.3 percent. The company’s net profit margin has achieved the current level of -73.6 percent and possesses 47.5 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 1 analysts call it Sell, while 15 think it is Hold. Recently, analysts have updated the overall rating to 3.04. 5 analysts recommended Overweight these shares while 6 recommended Underweight, according to FactSet data.
SK Telecom Co., Ltd. (NYSE:SKM) is worth US$16.95 Billion and has recently fallen -0.08% to US$23.54. The latest exchange of 0.42 Million shares is below its average trading activity of 468.24 Million shares. The day began at US$23.56 but the price moved to US$23.4 at one point during the trading and finally capitulating to a session high of US$23.56. The stock tapped a 52-week high of US$28.97 while the mean 12-month price target for the shares is US$32.6.
Currently, the stock carries a price to earnings ratio of 6.22, a price to book ratio of 0.85, and a price to sales ratio of 1.09. For the past 5 years, the company’s revenue has grown 1.2%, while the company’s earnings per share has grown 15%. With an institutional ownership near 11.8%, it carries an earnings per share ratio of 3.78.